TNF Pharmaceuticals Inc. (TNFA) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company listed on NASDAQ. There were no new wire items for TNFA in the last 30 days. The most recent was published Sep 26, 2025.

Latest news

25 items

TNFA FAQ

6 questions
  • What is the latest news on TNFA?
    Quantisnow has not tracked any new filings, ratings or press releases for TNFA in the last 30 days. The most recent wire item was published on September 26, 2025.
  • Where does TNFA stock trade?
    TNF Pharmaceuticals Inc. (TNFA) is listed on NASDAQ.
  • What sector and industry is TNFA in?
    TNF Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.
  • When did TNF Pharmaceuticals Inc. go public?
    TNF Pharmaceuticals Inc. (TNFA) completed its IPO in 2014.
  • What companies are similar to TNFA?
    Notable peers in the same industry include LNTH (Lantheus Holdings Inc.), NTLA (Intellia Therapeutics Inc.), ACHV (Achieve Life Sciences Inc.), ORKA (Oruka Therapeutics Inc.), CLDX (Celldex Therapeutics Inc.). Compare TNFA side-by-side with any of them on Quantisnow.
  • How can I track TNFA on Quantisnow?
    Quantisnow aggregates TNF Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TNFA to receive live email and push alerts on every new disclosure.